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Abstract 
Purpose: To investigate the in vitro growth-inhibitory effect of Calophyllum inophyllum, a medicinal 
plant traditionally used to cure gastrointestinal disorders caused by diarrhoea-causing bacteria. 
Methods: The minimum inhibitory concentration (MIC) of C. inophyllum ethanol leaf extract was 
determined against six diarrhoea-causing bacteria, namely, Clostridium difficile infant, Clostridium 
perfringens, Enterococcus faecalis, Escherichia coli, Listeria monocytogenes, and Salmonella enterica. 
The effect of the plant extract on bacterial growth kinetics was further evaluated by slightly modified 
broth microdilution method.  
Results: The plant extract showed significant inhibitory activity against C. perfringens and L. 
monocytogenes (MIC = 128 μg/mL) followed by C. difficile (MIC = 512 μg/mL). Monitored growth curves 
also showed that the plant extract at ½ MIC inhibits bacterial growth by distinct extension of the lag 
phase or suppression of the whole growth rate in C. difficile and L. monocytogenes, respectively. 
Conclusion: These results demonstrate the significant anti-clostridial and anti-listerial activities of C. 
inophyllum ethanol leaf extract. Thus, the extract seems to be a promising material for the development 
of new antibacterial agents. 
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Infectious diarrhoea still remains one of the main 
causes of global morbidity and mortality, 
especially in less developed countries for 
children aged under 5 years [1]. Bacterial agents 
associated with the most severe diarrhoeal 
episodes in these countries are Escherichia coli, 
Shigella spp., Campylobacter jejuni, Salmonella 
spp., and Vibrio cholera [2]. Other important 
diarrhoea-causing bacteria such as Clostridium 
spp., Listeria monocytogenes or Enterococcus 
faecalis are known to cause serious diseases 
even in the developed world [3]. Despite the high 
reduction of global mortality over the last few 
decades, especially due to the implementation of 
methods preventing fast dehydration of severely 
infected patients, diarrhoea remains one of the 
major human killers, and thus searching for 
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further effective treatment practices is more than 
advisable [4]. 
 
Although the use of common antibiotics could 
play the major role in controlling diarrhoeal 
infections by reducing mortality among severely 
immunocompromised [5] patients with invasive 
infections, by shortening the duration of an 
illness, or by decreasing secondary transmission 
of the pathogens [6]; their regular administration 
is in developing countries significantly restricted 
due to their low economical effectiveness [7], a 
high risk of serious side-effects, and the growing 
resistance of several causal pathogens [8]. 
Finding a new, low-cost, easily available, and 
side-effect-free alternative to common 
antimicrobial therapy is therefore needed, such 
that the use of products derived from medicinal 
herbs such as extracts and their phytochemicals 
becomes the promising option [9]. A good 
example from previous studies is goldenseal 
(Hydrastis canadensis L.), the plant traditionally 
used to treat gastrointestinal infections from 
which an active antimicrobial compound 
berberine was later isolated, nowadays offered at 
the international market to alleviate diarrhoea 
[10]. 
 
In the territory of Pacific Islands, diarrhoea 
causes the third greatest burden of all present 
diseases [11]. In correspondence with this, the 
proportion of local medicinal plants traditionally 
used to treat diarrhoea is quite high, especially in 
the South Pacific [12]. Among these countries, 
relatively high ratio of such medicinal plants is 
used in traditional herbal medicine of Western 
Samoa, whereas many of them have not been 
laboratory tested for their antimicrobial activity 
yet [13]. Therefore, we performed preliminary 
testing of ethanol extracts from 11 Samoan plant 
species, namely Calophyllum inophyllum, 
Cordyline fruticosa, Inocarpus fagifer, 
Mussaenda raiateensis, Piper graeffei, Pometia 
pinnata, Premna serratifolia, Spondias dulcis, 
Syzygium malaccense, Thespesia populnea, and 
Trema cannabina against diarrhoea-causing 
bacteria. Among these species, the extract of 
leaves of C.inophyllum produced results worth 
further investigation (T. Kudera and L. Kokoska, 
unpublished data). 
 
C. inophyllum L. (Calophyllaceae), commonly 
known as Alexandrian laurel, is an evergreen 
medium to large tropical tree widely distributed 
along the coasts of Indian and Pacific Oceans 
especially in Melanesia and Polynesia [14]. 
Among its various medicinal uses throughout 
these regions [15], only in Western Samoa where 
the leaf infusion is traditionally used to treat 
diarrhoea [13]. Despite the existence of previous 
studies reporting the antimicrobial activity of this 
part of the plant [16], a detailed research focused 
on its effect against diarrhoea-causing bacteria is 
still lacking. In the present study, we therefore 
examined in vitro growth-inhibitory effect of 







The leaves of C. inophyllum were collected from 
the trees growing in the coastal areas of the 
capital city Apia (13°49'43.5"S 171°46'01.5"W), 
located at Upolu island of the Independent State 
of Samoa, in September 2015. The plant was 
authenticated by Tomas Kudera and a voucher 
specimen (no. 2404KBFR0) has been deposited 
in the herbarium of the Department of Botany 
and Plant Physiology of the Faculty of 
Agrobiology, Food and Natural Resources of the 
Czech University of Life Sciences Prague (CZ). 
 
Preparation of plant extracts 
 
Dried sample of C. inophyllum leaves was 
homogenized using Grindomix mill (Retsch, 
Haan, DE) and 15 g of dry matter was extracted 
for 24 h in 450 ml 80 % ethanol (Sigma-Aldrich, 
Prague, CZ) at room temperature using 
laboratory shaker (GFL, Burgwedel, DE). The 
extract was then filtered and concentrated using 
rotary evaporator (Büchi Labortechnik, Flawil, 
CH) in vacuo at 40 °C. Dried residues were 
subsequently diluted in 100 % dimethyl sulfoxide 
(Penta, Prague, CZ) to obtain stock solution of 
the final concentration 51.2 mg/mL and stored at 
-20 °C until their use. The yield of dry residues 
was 16.6 %. 
 
Microorganisms and media 
 
The antibacterial activity was determined against 
six representatives of both Gram-positive/-
negative and aerobic/anerobic diarrhoea-causing 
bacteria. Standard American Type Culture 
Collection (ATCC) strains, namely E. faecalis 
ATCC 29212, E. coli ATCC 25922, L. 
monocytogenes ATCC 7644, S. enterica ATCC 
13076, were obtained from Oxoid (Basingstoke, 
UK). C. perfringens DSM 11778, was purchased 
from the German Resource Centre for Biological 
Material (DSMZ) (Braunschweig, DE). C. difficile 
infant KK4 was isolated from faecal samples of 
healthy infants aged from 1 to 6 months. Mueller-
Hinton broth (MHB) (Oxoid, Basingstoke, UK) 
was used as a growth medium for all tested 
aerobic bacteria, whereas further 
supplementation by 1 % of glucose (Sigma-
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Aldrich, Prague, CZ) was done in case of E. 
faecalis. Both anaerobs (clostridia) were in 
difference cultured in Wilkins-Chalgren broth 
(Oxoid, Basingstoke, UK) enriched by 5 g/L soya 
peptone and 0.5 g/L cystein, grown under 
anaerobic condition.  
 
Determination of minimum inhibitory 
concentrations (MIC) 
 
For the effective assessment of in vitro 
antimicrobial activity, the specific broth 
microdilution method using 96-well microtiter 
plates was employed according to the guidelines 
of the Clinical and Laboratory Standards Institute 
(CLSI) [17], modified by Cos et al [18]. C. 
inophyllum extract was twofold diluted in MHB 
(100 μL) in a ranges of 1-512 μg/mL using 
automated pipetting platform Freedom EVO 100 
(Tecan, Männedorf, CH) and a manual 
multichannel pipette (Eppendorf, Wesseling-
Berzdorf, DE) for assessment of aerobic and 
anaerobic bacteria, respectively. All bacterial 
cultures were diluted to contain 1.5 × 108 
CFU/mL and subsequently inoculated with the 
suspension in microtiter plate. Microplates were 
then incubated for 24 h at 37 °C. The plates 
inoculated with clostridia were prepared and 
incubated in Whitley A35 Anaerobic Workstation 
(Don Whitley Scientific, West Yorkshire, UK). 
Bacterial growth was determined by the 
absorbance measurement by Cytation 3 Imaging 
Reader (BioTek, Vermont, USA) at 405 nm. The 
lowest extract concentration showing at least ≥80 
% reduction of microbial growth compared to the 
positive growth control was considered as MIC. 
Tetracycline (Sigma-Aldrich, Prague, CZ), 
previously dissolved in ethanol (Lach-Ner, 
Neratovice, CZ), was tested as positive antibiotic 
control in concentration range of 0.125 - 64 
μg/mL for aerobic bacteria and C. perfringens, 
whereas for C. difficile the antibiotic was diluted 
in a range of 0.015625-8 μg/mL. All tests were 
performed as three independent experiments 
each carried out in triplicate, and the final results 
are presented as median/modal values. 
 
Bacterial growth kinetics analysis 
 
For monitoring of bacterial growth kinetics, the 
protocol of broth microdilution method described 
above was used with following modifications. 
Plant extract was 2-fold diluted in MHB in ranges 
of 16-512 μg/mL, whereas tetracycline was 
prepared in ranges of 2 - 64, 0.0156 - 0.50 and 4 
- 128 μg/mL for aerobic bacteria, C. difficile and 
C. perfringens, respectively. During 24 h of 
incubation, absorbance measurements were 
performed every hour and the regular orbital 
shaking conditions were selected. The plates 
inoculated with anaerobes were prepared and 
incubated in Whitley A35 Anaerobic Workstation 
and manually withdrawn every hour for each 
absorbance measurement. To avoid oxygen 
contamination that could negatively affect growth 
of the anaerobic bacteria, for each measurement 
a special solitary plate was prepared (i.e., 25 
identical plate copies for each experiment). All 
experiments were performed along with positive 
controls, neither with plant extract nor with 
tetracycline, to obtain reference growth curves. 
Results are presented as curves of bacterial 
growth calculated as the mean values of two 
independent experiments each performed in 





Minimum inhibitory concentration (MIC) 
 
The growth-inhibitory effects of C. inophyllum 
ethanol leaf extract was determined in vitro for 
six representatives of both aerobic and anerobic 
diarrhoea-causing bacteria (Gram-positive and -
negative) as MIC values. The data on 
susceptibility of all tested bacterial pathogens are 
summarized in Table 1. The results show that the 
most significant inhibitory effect was observed 
against C. perfringens and L. monocytogenes 
(MIC = 128 μg/mL), followed by moderate activity 
against C. difficile (MIC = 512 μg/mL). No 
inhibitory activity was observed against E. 
faecalis, E. coli and S. enterica. In general, 
Gram-positive strains were more susceptible to 
C. inophyllum ethanol leaf extract than Gram-
negative ones. Tetracycline as the positive 
antibiotic control produced MICs in a range of 
0.0625-16 μg/mL. 
 
Table 1: In vitro growth-inhibitory effect of C. 






Clostridium difficile 512 0.0625 
Clostridium perfringens 128 16 
Enterococcus faecalis >512 16 
Escherichia coli >512 1 
Listeria monocytogenes 128 0.25 
Salmonella enterica >512 2 
aMIC = minimum inhibitory concentration (data are 
median or modal values of three independent 
experiments, each performed in triplicate) 
 
Bacterial growth kinetics  
 
The analysis of bacterial growth over 24 h in 
presence of different concentrations of C. 
inophyllum ethanol leaf extract compared to the 
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standard growth and the positive antibiotic 
(tetracycline) controls was performed for all six 
diarrhoea-causing bacteria tested. The results, 
presented as growth curves of standard culture, 
MIC, and 1/2 of MIC (Figure 1), showed the 
concentration-dependent inhibitory effect of the 
tested plant extract on bacterial growth kinetics 
of C. difficile, C. perfringens, and L. 
monocytogenes. 
 
Considering the growth of standard cultures, the 
results showed that all three bacteria exhibited 
slightly different growth kinetics. The exponential 
phase starts immediately at the beginning of the 
incubation of C. perfringens, whereas the lag 
phase of 5 and 3 h was needed in cases of C. 
difficile and L. monocytogenes, respectively. 
However, both clostridia then similarly exhibited 
a rapid exponential growth reaching further 
predominating stationary phase, which was in 
case of L. monocytogenes completely missing.  
 
The growth of bacteria exposed to C. inophyllum 
extract and tetracycline at their MIC have 
confirmed the results obtained during the MIC 
endpoints determination. Therefore, the final 
absorbance values of bacterial growth were 
generally reduced by ≥80 % and no significant 
growth was observed during the whole 24 h of 
incubation period. In contrast, bacteria cultured in 
presence of plant extract and antibiotic at their1/2 
of MICs always exhibited the growth that was 
generally modified as follows: the lag phase was 
extended or/and the growth rate was suppressed 
resulting in a shallower curve giving a reduced 
final absorbance value. The longest delay of the 
onset of exponential phase caused by the 
presence of C. inophyllum ethanol leaf extract 
was observed in growth of C. difficile at 
concentration 256 μg/mL, where the lag phase 
was extended by approximately 14 h (Figure 1A).  
 
Similarly large extension of the lag phase of C. 
difficile growth was also caused by tetracycline at 
concentration 0.03125 μg/mL (Figure 1B). Rather 
shorter delay of the onset of exponential growth 
(about 3 h) was caused by the tested plant 
extract at concentration 64 μg/mL in growth of C. 
perfringens (Figure 1C). In this case, the lag 
phase extension was considerably larger (about 
10 h) when the bacteria were exposed to 8 
μg/mL of tetracycline (Figure 1D). The growth of 
L. monocytogenes at ½ MIC of C. inophyllum 
ethanol leaf extract (64 μg/mL) was significantly 
suppressed and the maximum slope of the 
exponential phase was distinctly declined (Figure 
1E). In case of tetracycline, the initial growth rate 
has also been reduced, however, after 14 h of 
incubation the exponential growth suddenly 
increased reaching the final absorbance value 




The results of this study showed significant in 
vitro growth-inhibitory effect of C. inophyllum 
extract against three Gram-positive diarrhoea-
causing bacteria, namely C. difficile, C. 
perfringens, and L. monocytogenes. In 
correspondence with our findings, Ali et al [16] 
described a potential activity of buthanol, 
chloroform and ethanol leaf extracts of C. 
inophyllum against Gram-positive bacteria. 
Despite the existence of above mentioned study, 
there are no reports on antibacterial effect of the 
extract on specific growth-kinetic curves of the 
tested pathogens. In addition, this is the first 
report on its anti-clostridial and anti-listerial 
effect. 
 
As far as the chemical constituents responsible 
for antibacterial action of the extract are 
concerned, various classes of secondary 
metabolites such as coumarins, flavonoids, 
triterpenes, and xanthones have previously been 
identified as the main bioactive constituents of 
the plant [19]. For example, Yimdjo et al [20] 
described antibacterial effect of some calophyllic 
acid, phenylcoumarine, and xanthone derivatives 
isolated from root bark and seed against S. 
aureus, whereas calophyllolide was a compound 
with the highest activity. Since C. inophyllum 
leaves are known as a rich source of the same 
constituents [21], it is possible to suppose that 
they could contribute to their anti-clostridial and 
anti-listerial action observed in this study. 
Another group of compounds present in relatively 
high amounts in C. inophyllum leaves are 
friedelin-type triterpenoids, such as canophyllol, 
canophyllic acid, and friedelin [22]. Ali et al [16] 
described their significant inhibitory effect against 
Gram-positive (Corynebacterium diptheriae, 
Staphylococcus aureus) and Gram-negative 
(Klebsiella pneumoniae, S.typhi, Proteus 
mirabillis) bacteria. In another study, Noundou et 
al [23] reported a high inhibitory effect of friedelin 
against Bacillus cereus, E. faecalis, and E. coli 
with MICs values in a range of 16-63 μg/mL. 
Nevertheless, the studies evaluating anti-
clostridial and anti-listerial effect of all above 
mentioned compounds are missing. 
 
Whereas C. perfringens and L. monocytogenes 
are known as typical foodborne pathogens 
causing diarrhoea, C. difficile infections are 
generally linked with antibiotic-associated 
diarrhoea observed in hospitalised patients [3]. 
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Figure 1: Growth kinetics of C. difficile (A, B), C. perfringens (C, D), and L. monocytogenes (E, F) over 24 h of 
incubation in presence of various concentrations of C. inophyllum ethanol leaf extract (A, C, E) and tetracycline 
(B, D, F), compared to their standard culture growth. All graphs contain three growth curves: Growth control (■); 
growth at MIC (●) [512 (A), 0.0625 (B), 128 (CE), 16 (D), 0.25 (F) μg/mL]; and the growth at 1/2 of MIC (∆) [256 
(A), 0.03125 (B), 64 (CE), 8 (D), 0.125 (F) μg/mL]. 
 
Besides the option of using C. inophyllum leaves 
to treat diarrhoea by inhibition of gut pathogenic 
bacteria, its application as food preservative 
could be another way of its utilisation as it has 
already been hypothesised in previous studies. 
For example, Odedina et al [24] described a high 
anti-listerial potential of Rhodomyrtus tomentosa 
ethanol leaf extract for further new food 
preservative development. Despite the fact that 
C. inophyllum ethanol leaf extract shows a 
promising antibacterial activity, its safety profile is 
crucial aspect for practical future application. As 
the folk medicinal preparations from C. 
inophyllum leaves are particularly applied 
externally (healing of skin and eye disorders 
[12]), there is significant evidence of their oral 
administration [13,15]. Although Carratu et al [25] 
classified C. inophyllum as not admitted in food 
supplements due to the presence of resins, there 
are actually no existing toxicological studies on 
the oral toxicity of this plant part. Therefore, a 
pharmacological and toxicological evaluation of 
the plant is needed before considering further 





The findings of this study show the significant in 
vitro growth-inhibitory effect of C. inophyllum 
ethanol leaf extract against diarrhoea-causing 
bacteria C. difficile, C. perfringens and L. 
monocytogenes. Bacterial growth kinetic data 
demonstrate that the plant extract markedly 
inhibits the growth of the pathogens by significant 
extension of the lag phase or suppression of the 
whole growth rate as observed for C. difficile and 
L. monocytogenes, respectively. These results 
can be therefore helpful in further research 
targeting the development of new anti-clostridial 
Kudera et al 
Trop J Pharm Res, September 2017; 16(9): 2212  
 
and anti-listerial agents derived from the active 
antibacterial constituents isolated from C. 
inophyllum leaves. However, further 
pharmacological and toxicological evaluation is 
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